查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1832076

奈米孔技術市場規模、佔有率、趨勢及預測（按產品、應用、最終用戶和地區），2025 年至 2033 年

Nanopore Technologies Market Size, Share, Trends and Forecast by Product, Application, End User, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球奈米孔技術市場規模為 3.08 億美元。展望未來， IMARC Group估計到 2033 年市場規模將達到 7.865 億美元，2025-2033 年期間的複合年成長率為 11.0%。北美目前佔據市場主導地位，2024 年市佔率將超過 41.2%。全球市場主要受精準醫療需求成長、即時且經濟高效的 DNA/RNA 測序、診斷和藥物發現應用的不斷擴大、測序準確性和便攜性的提高、研究投資的增加以及基因組學、蛋白質組學和個性化醫療解決方案的日益普及等因素驅動。

由於奈米孔技術能夠提供即時、經濟高效的 DNA 和 RNA 定序，精準醫療和基因分析的需求不斷成長，推動了全球市場的發展。此外，奈米孔技術在診斷工具、藥物研發和個人化醫療領域的應用日益廣泛，也推動了市場的成長。此外，定序精度的不斷提高、成本的降低和吞吐量的提升，進一步為奈米孔技術市場帶來了積極的前景。此外，對快速便攜診斷的需求日益成長，基因組學和蛋白​​質組學領域的持續努力以及研究投入的增加，也促進了市場的擴張。例如，2025 年 1 月 13 日，Truveta 宣布獲得 Regeneron Pharmaceuticals、Illumina 和 17 家美國醫療系統的 3.2 億美元投資，以創建全球最大的基因資料庫。該計劃旨在彙編 1000 萬個基因組序列，以增強藥物研發和患者護理。 Regeneron 將出資 1.2 億美元進行定序，而 Illumina 將出資 2,000 萬美元。該計畫將在規模和多樣性上擴展這項工作，以包括患者同意的匿名醫療記錄和樣本。

美國是一個重要的區域市場，主要原因是癌症和心血管疾病等慢性疾病的發生率不斷上升。例如，美國食品藥物管理局報告稱，美國十大死因中有七種是常見慢性疾病 (CCD)，其中心血管疾病、糖尿病、肥胖症和某些癌症等飲食相關疾病的發生率顯著上升。美國的飲食相關疾病發生率落後於42個國家，且仍有2,800萬美國人吸煙，這加劇了對獨特治療干預措施的需求。微生物學和環境監測領域的研究活動日益增多，奈米孔設備可用於檢測病原體和污染物。此外，人工智慧與奈米孔技術的結合正在提高資料分析和診斷的準確性。此外，醫療保健和農業部門需要即時、高效的現場檢測，這也促進了市場成長。美國強大的醫療基礎設施和政府對生物技術創新的支持措施正在進一步加速奈米孔技術的普及。

奈米孔技術市場趨勢：

擴大臨床應用

奈米孔測序因其能夠即時測序長鏈DNA或RNA而日益受到臨床診斷領域的青睞。其在傳染病診斷領域具有變革性的力量，可以加快病原體識別速度，並顯著改善患者的預後。奈米孔技術能夠分析結構變異、甲基化模式和基因融合，這些對於制定個人化治療策略至關重要，因此在癌症基因組學領域的應用也日益廣泛。 2024年9月發表的一項研究探討了牛津奈米孔定序在評估醫院環境中感染傳播可能性方面的應用，但並未提供使用該技術的醫院數量的資料。 2024年6月的另一項研究重點關注了紐西蘭一家四級醫院的奈米孔定序基準測試和品質控制，顯示該技術正在特定機構中得到應用。與傳統定序相比，奈米孔技術無需擴增或大量的樣品製備，因此在臨床應用中非常有效率。奈米孔定序的多功能性和持續下降的成本使其成為精準醫療的核心技術。該技術能夠滿足新興的醫療保健需求，例如監測流行病和管理抗菌素抗藥性，進一步強調了其徹底改變臨床應用和推動奈米孔技術市場持續成長的潛力。

攜帶式設備的進步

奈米孔技術正透過攜帶式定序設備的快速發展，徹底改變基因分析的可及性和可用性。牛津奈米孔公司的 MinION 因其緊湊的外形、實惠的價格以及測序結果的即時交付而廣受歡迎。截至 2023 年，MinION 設備已在 100 多個國家投入使用，彰顯了其全球影響力。借助這些攜帶式設備，研究人員和醫療保健提供者能夠在偏遠地區和資源有限的各種環境中進行現場基因分析。這種便攜性在野外病原體監測、農業基因組學和環境監測等應用中尤其有益，因為在野外建立整個實驗室是不切實際的。此外，雲端分析平台與可攜式裝置的整合往往會增強其功能，實現即時資料共享和協作。人們越來越重視開發方便用戶使用且性能強大的設備，這使得定序技術的使用更加普及，從而擴大了奈米孔技術的市場佔有率。

基因組研究投資不斷增加

除私人企業外，政府和學術機構對基因組研究的投資不斷增加，這是奈米孔技術市場成長的因素。根據最近的資料，美國國立衛生研究院 (NIH) 已撥款高達 2700 萬美元用於建立基於基因組學的學習健康系統，並在第一年撥款 540 萬美元用於將基因組學融入患者護理。這些措施強調了人們越來越重視利用先進的定序技術（如奈米孔平台）來改善醫療保健結果。這些投資有望幫助更了解遺傳訊息的性質及其對健康、農業和環境科學的意義。美國和中國等國的人類基因組計劃和國家基因組研究計劃等資助計劃正在推動測序技術的創新，包括基於奈米孔的平台。私部門參與者也正在投入大量資源開發尖端奈米孔設備，以滿足對更快、更便宜、更準確的定序解決方案日益成長的需求。資金的湧入正在加速技術進步，並賦能個人化醫療、合成生物學等領域的新應用。研究資金的穩定成長凸顯了奈米孔技術在更廣泛的基因組學生態系統中發揮的關鍵作用。

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 二手資料
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

第5章：全球奈米孔技術市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依產品

  • 儀器
    • 關鍵部分
      • 便攜的
      • 桌上型
  • 耗材

第7章：市場區隔：依應用

  • DNA定序
  • RNA定序
  • 其他

第 8 章：市場區隔：依最終用戶

  • 醫院和診所
  • 研究機構
  • 其他

第9章：市場細分：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第 10 章：SWOT 分析

第 11 章：價值鏈分析

第 12 章：波特五力分析

第13章：價格分析

第 14 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Agilent Technologies Inc.
    • Cyclomics BV
    • Electronic Biosciences Inc.
    • Inanobio Inc.
    • Nabsys Inc.
    • Ontera Inc.
    • Oxford Nanopore Technologies Limited
    • Pacific Biosciences of California Inc.
    • Quantapore Inc.
    • Roche Holding AG
    • Tracxn Technologies Limited
Product Code: SR112025A4718

The global nanopore technologies market size was valued at USD 308.0 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 786.5 Million by 2033, exhibiting a CAGR of 11.0% during 2025-2033. North America currently dominates the market, holding a significant market share of over 41.2% in 2024. The global market is majorly driven by rising demand for precision medicine, real-time and cost-effective DNA/RNA sequencing, expanding applications in diagnostics and drug discovery, advancements in sequencing accuracy and portability, increasing research investments, and growing adoption in genomics, proteomics, and personalized healthcare solutions.

The global market is primarily driven by the increasing demand for precision medicine and genetic analysis as nanopore technology offers real-time, cost-effective sequencing of DNA and RNA. Moreover, the growing applications in diagnostic tools, drug discovery, and personalized medicine are fueling market growth. Additionally, ongoing advancements in sequencing accuracy, reduced costs, and improved throughput capabilities are further creating a positive nanopore technologies market outlook. Moreover, the rising need for rapid, portable diagnostics and the ongoing efforts in the fields of genomics and proteomics are also contributing to the market's expansion, along with increased research investments. For instance, on January 13, 2025, Truveta announced a USD 320 Million investment from Regeneron Pharmaceuticals, Illumina, and 17 U.S. health systems to create the world's largest genetic database. This initiative aims to compile 10 million genomic sequences, enhancing drug discovery and patient care. Regeneron will contribute USD 120 Million and conduct the sequencing, while Illumina will invest USD 20 Million. The project will extend this work in scale and diversity to include patient-consented, anonymized medical records and specimens.

The United States stands out as a key regional market, primarily driven by the prevalence of chronic diseases such as cancer and cardiovascular conditions is rising. For instance, U.S. Food & Drug Administration reported that seven of the ten major causes of death in the U.S. are common chronic diseases (CCDs), with diet-related illnesses such as cardiovascular disease, diabetes, obesity, and certain cancers contributing significantly. The U.S. ranks behind 42 countries in diet-related disease rates, and 28 million Americans continue to smoke, which is fueling the need for unique therapeutic intervention. increasing research activities in the areas of microbiology and environmental monitoring where nanopore devices are used for the detection of pathogens and contaminants. In addition, the integration of artificial intelligence with nanopore technology is improving the data analysis and the diagnostic accuracy. Furthermore, the healthcare and agricultural sector demands immediate, efficient, and on-site tests, which is contributing to market growth. The country's strong healthcare infrastructure and favorable government initiatives for the support of biotech innovations are accelerating the adoption of nanopore technologies further.

Nanopore Technologies Market Trends:

Expanding Clinical Applications

Nanopore sequencing is increasingly becoming popular in clinical diagnostics as it has the capability to sequence long DNA or RNA strands in real-time. Its transformative power is in infectious disease diagnostics, where pathogen identification becomes faster and greatly improves patient outcome. Applications in cancer genomics are increasing as nanopore technologies enable the analysis of structural variants, methylation patterns, and gene fusions that are important for the formulation of personalized treatment strategies. A study published in September 2024 discusses the application of Oxford Nanopore sequencing to assess the possible transmission of infections within a hospital setting, but it does not provide data on the number of hospitals using the technology. Another study from June 2024 focuses on benchmarking and quality control for nanopore sequencing in a single quaternary hospital in New Zealand, indicating that the technology is being implemented in specific institutions. In contrast to conventional sequencing, nanopore technology does not require amplification or extensive sample preparation, making it very efficient for clinical use. Its versatility and declining costs are setting nanopore sequencing as a core technology in precision medicine. The adaptability of the technology to address emerging healthcare needs, such as monitoring pandemics and managing antimicrobial resistance, further emphasizes its potential to revolutionize clinical applications and drive sustained nanopore technologies market growth.

Advancements in Portable Devices

Nanopore technologies are revolutionizing the accessibility and usability of genetic analysis through rapid developments in portable sequencing devices. The Oxford Nanopore's MinION has been popular in its compact form, affordability, and real-time delivery of sequencing results. As of 2023, the MinION device has been used in over 100 countries, highlighting its global reach. Researchers and healthcare providers are empowered by these portable devices to conduct onsite genetic analyses within diverse environments- remote and resource limited. This portability is significantly beneficial in applications such as field-based pathogen surveillance, agricultural genomics, and environmental monitoring as it is impractical to set up a whole laboratory in the field. Besides that, the integration of cloud-based analysis platforms with portable devices tends to enhance their functionality, allowing real-time data sharing and collaboration. The increasing emphasis on the development of user-friendly and robust devices is democratizing access to sequencing technologies, expanding nanopore technologies market share.

Rising Investments in Genomic Research

Increasing investment by governments and academic institutions, in addition to private enterprises, into genomic research is a growth factor for the nanopore technologies market. According to recent data, the National Institutes of Health (NIH) has allocated up to USD 27 Million to establish genomics-enabled learning health systems and has earmarked USD 5.4 Million for the first year to integrate genomics into patient care. These initiatives underscore the growing emphasis on leveraging advanced sequencing technologies, such as nanopore platforms, for improving healthcare outcomes. These investments are expected to help better understand the nature of genetic information and what that might mean for health, agriculture, and environmental sciences. Funding initiatives such as the Human Genome Project and national genomic research programs in countries such as the U.S. and China are fueling innovation in sequencing technologies, including nanopore-based platforms. Private-sector players are also channeling significant resources into the development of cutting-edge nanopore devices to meet the rising demand for faster, cheaper, and more accurate sequencing solutions. This influx of funding is accelerating technological advancements and enabling new applications in personalized medicine, synthetic biology, and more. The steady growth in research funding underscores the pivotal role nanopore technologies play in the broader genomics ecosystem.

Nanopore Technologies Industry Segmentation:

Analysis by Product:

  • Instruments
    • Portable
    • Benchtop
  • Consumables

Consumables lead the market with around 55.0% of market share in 2024. The dominance of consumables in the nanopore technologies market is driven by the recurring demand for sequencing processes, such as flow cells, reagents, and sample preparation kits. These are essential components that ensure the performance and accuracy of nanopore devices, and thus, research institutions, healthcare providers, and diagnostic labs continue to purchase them. The growing need for personalized medicine and real-time sequencing applications ensures the sustained demand for consumables in the nanopore technologies market. Moreover, consumable design is being improved, with higher throughput flow cells and specialized reagents that are improving efficiency and lowering costs, which further increases adoption.

Analysis by Application:

  • DNA Sequencing
  • RNA Sequencing
  • Others

DNA sequencing leads the market with around 60.0% of market share in 2024. DNA sequencing plays a vital role in the nanopore technologies market as it gives real-time and long-read sequences that provide invaluable information about genetics. Moreover, the technology is cost-effective and portable for wide use in research and clinic settings, thereby making the nanopore market valuable. These are especially applied in the determination of complex variations, structural rearrangements, and epigenetic modifications. The growing demand for precision medicine and improvements in the speed and accuracy of sequencing will further support the application of this technology in the diagnosis of diseases, personalized treatment, and studies of evolution. Also, the greater integration of nanopore DNA sequencing in agriculture and microbiology strengthens its market leadership.

Analysis by End User:

  • Hospitals and Clinics
  • Research Institutes
  • Others

Research institutes lead the market with around 45.3% of market share in 2024. The market for nanopore technologies is dominated by research institutes due to the substantial contribution these institutes have toward genomic studies, molecular biology, and biotechnology. These institutes significantly apply nanopore sequencing to diverse applications such as genetic mutations, rare diseases, and the study of microbiomes. This nanopore platform's flexibility and scalability provide advanced research capabilities in areas such as transcriptomics and epigenetics. The development of grants and government funding for scientific research also increases adoption, together with cooperation by a large number of research institutes, which implements innovation through improved sequencing accuracy and efficiency, resulting in their dominant position in the market.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

In 2024, North America accounted for the largest market share of over 41.2% due to its superior healthcare infrastructure and substantial investments in biotechnology and genomic research. The region benefits from the presence of key industry players and has vast government funding for precision medicine and genomics. Furthermore, the acceptance of innovative technologies, including real-time sequencing and AI integration, is also speeding up the growth of the market. The demand from individualized medicines, diagnostics, agricultural, and environmental sectors forms further support for the market.

Key Regional Takeaways:

United States Nanopore Technologies Market Analysis

In 2024, the US accounted for around 78.90% of the total North America nanopore technologies market. The U.S. nanopore technologies market is rising fast with immense investment in genomics and healthcare innovations. The NIH has granted up to USD 27 Million to create a network of genomics-enabled learning health systems and allocated USD 5.4 Million for the first year to embed genomics in patient care. All these efforts are enriching the application of nanopore-based sequencing in real-time clinical decision-making and disease management. Companies such as Oxford Nanopore Technologies are seizing the momentum with high-end, low-cost sequencing solutions. Market growth is driven by precision medicine and increased funding in genomic research. Through its collaborations with industries and the supportive role of the U.S. government towards innovative biotechnology activities, the United States is establishing its position as one of the global leaders in nanopore technologies.

Europe Nanopore Technologies Market Analysis

The nanopore technologies market in Europe is growing steadily with the rise in investments in genomic research and healthcare initiatives. Eurostat statistics revealed that the EU has set aside EUR 1.8 Billion (USD 1.9 Billion) in 2022 toward biotech innovation, most of which targets nanopore sequencing. The UK and Germany are the leaders, and institutions such as the Francis Crick Institute drive cutting-edge research. The adoption of nanopore technologies in next-generation sequencing is also on the rise in clinical diagnostics, especially in rare diseases. Moreover, personalized medicine has become a major emphasis in the EU, such as through Horizon Europe, further fostering nanopore technologies market demand. . With biotech growth being supported by regulatory frameworks, Europe will be an excellent player in the global market of nanopore technology.

Asia Pacific Nanopore Technologies Market Analysis

The Asia Pacific nanopore technologies market is growing rapidly due to increased investments in genomics and healthcare advancement. Chinese nanopore sequencing company Qitan Tech raised a Series C round of RMB 700 Million (or about USD 103.7 Million) back in January 2023. This is significant private sector interest in the area. Countries such as China and India have focused heavily on genomic research and clinical applications, with initiatives such as "Make in India" enhancing domestic innovation in sequencing technologies. Further pushing market growth will be the increasing interest in personalized medicine and infectious disease detection in Japan and South Korea. Acceleration of innovation through collaborative partnerships between local and global players, increased government funding, and development of healthcare infrastructure are making the region a significant contributor to the global nanopore technologies market.

Latin America Nanopore Technologies Market Analysis

Latin American nanopore technologies are growing with investments in genomics and biotechnology. For example, the National Fund for Scientific and Technological Development in Brazil was given more resources in the 2023 fiscal year according to Law No. 14.577 by Global Trade Alert. These resources support scientific research and innovation, including advancements in genomics. Countries such as Mexico and Colombia are also focusing on genomic research for regional health challenges, which is propelling the demand for innovative sequencing technologies. Private investments along with government initiatives are encouraging the collaboration of local researchers with international players, which will fuel the market growth. Further, the developing healthcare infrastructure along with the increased focus on precision medicine is emerging Latin America as a new hub in the global nanopore technologies market.

Middle East and Africa Nanopore Technologies Market Analysis

Nanopore technologies market in the Middle East and Africa is picking up as more investment in healthcare innovation takes place. For instance, the UAE's federal budget for 2023 had AED 63.066 Billion, or about USD 17.17 Billion, allocated to total expenditures. Of that amount, AED 4.8 Billion, or about USD 1.31 Billion, was allocated to healthcare and community protection (Ministry of Finance). The Emirati Genome Program also focuses on the complete sequencing of the Emirati genome to improve personalized healthcare. All these programs indicate the heavy incorporation of cutting-edge genomic technology within the health sector. Collaboration with international biotech companies and increasing investment in sequencing technologies in precision medicine is driving growth in the market. Expanding health infrastructure and government-sponsored research programs put the region as a fast-growing contributor to the global landscape of nanopore technologies.

Competitive Landscape:

The market is characterized by the presence of numerous established players and emerging innovators striving to enhance sequencing technologies. Companies are heavily investing in research and development to improve accuracy, throughput, and affordability, fostering a dynamic environment of technological advancements. Strategic partnerships, licensing agreements, and collaborations with academic institutions are prevalent, facilitating innovation and expanding application areas. In addition, market participants are focusing on miniaturization and portability of devices, catering to the rising demand for point-of-care diagnostics and field-based testing solutions across various sectors. Notably, on November 5, 2024, Oxford Nanopore Technologies announced its partnership with UK health agencies to speed up pathogen screening across up to 30 NHS sites. The partnership will identify severe respiratory infections and recommend treatments within six hours of sample collection, thus bolstering early warning systems for pandemic threats. Oxford Nanopore's long-read sequencing technology will be used in the project to improve monitoring of emerging bacterial and viral threats and the spread of drug-resistant pathogens.

The report provides a comprehensive analysis of the competitive landscape in the nanopore technologies market with detailed profiles of all major companies, including:

  • Agilent Technologies Inc.
  • Cyclomics BV
  • Electronic Biosciences Inc.
  • Inanobio Inc.
  • Nabsys Inc.
  • Ontera Inc.
  • Oxford Nanopore Technologies Limited
  • Pacific Biosciences of California Inc.
  • Quantapore Inc.
  • Roche Holding AG
  • Tracxn Technologies Limited

Key Questions Answered in This Report

  • 1.How big is the nanopore technologies market?
  • 2.What is the future outlook of nanopore technologies market?
  • 3.What are the key factors driving the nanopore technologies market?
  • 4.Which region accounts for the largest nanopore technologies market share?
  • 5.Which are the leading companies in the global nanopore technologies market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Nanopore Technologies Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Portable
      • 6.1.2.2 Benchtop
    • 6.1.3 Market Forecast
  • 6.2 Consumables
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Application

  • 7.1 DNA Sequencing
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 RNA Sequencing
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals and Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Research Institutes
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Agilent Technologies Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Cyclomics BV
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Electronic Biosciences Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Inanobio Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Nabsys Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Ontera Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Oxford Nanopore Technologies Limited
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8 Pacific Biosciences of California Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 Quantapore Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Roche Holding AG
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
    • 14.3.11 Tracxn Technologies Limited
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: Nanopore Technologies Market: Major Drivers and Challenges
  • Figure 2: Global: Nanopore Technologies Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 4: Global: Nanopore Technologies Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Nanopore Technologies Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Nanopore Technologies Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Nanopore Technologies Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Nanopore Technologies (Instruments) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Nanopore Technologies (Instruments) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Nanopore Technologies (Consumables) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Nanopore Technologies (Consumables) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Nanopore Technologies (DNA Sequencing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Nanopore Technologies (DNA Sequencing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Nanopore Technologies (RNA Sequencing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Nanopore Technologies (RNA Sequencing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Nanopore Technologies (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Nanopore Technologies (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Nanopore Technologies (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Nanopore Technologies (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Nanopore Technologies (Research Institutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Nanopore Technologies (Research Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Nanopore Technologies (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Nanopore Technologies (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: North America: Nanopore Technologies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: North America: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: United States: Nanopore Technologies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: United States: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Canada: Nanopore Technologies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Canada: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Asia-Pacific: Nanopore Technologies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Asia-Pacific: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: China: Nanopore Technologies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: China: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Japan: Nanopore Technologies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Japan: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: India: Nanopore Technologies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: India: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: South Korea: Nanopore Technologies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: South Korea: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Australia: Nanopore Technologies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Australia: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Indonesia: Nanopore Technologies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Indonesia: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Others: Nanopore Technologies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Others: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Europe: Nanopore Technologies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Europe: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Germany: Nanopore Technologies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Germany: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: France: Nanopore Technologies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: France: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: United Kingdom: Nanopore Technologies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: United Kingdom: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Italy: Nanopore Technologies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Italy: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Spain: Nanopore Technologies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Spain: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Russia: Nanopore Technologies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Russia: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Others: Nanopore Technologies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Others: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Latin America: Nanopore Technologies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Latin America: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Brazil: Nanopore Technologies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Brazil: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Mexico: Nanopore Technologies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Mexico: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Others: Nanopore Technologies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Others: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Middle East and Africa: Nanopore Technologies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Middle East and Africa: Nanopore Technologies Market: Breakup by Country (in %), 2024
  • Figure 72: Middle East and Africa: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Global: Nanopore Technologies Industry: SWOT Analysis
  • Figure 74: Global: Nanopore Technologies Industry: Value Chain Analysis
  • Figure 75: Global: Nanopore Technologies Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Nanopore Technologies Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Nanopore Technologies Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Nanopore Technologies Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Nanopore Technologies Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Nanopore Technologies Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Nanopore Technologies Market: Competitive Structure
  • Table 7: Global: Nanopore Technologies Market: Key Players